Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.5 USD | -0.07% | +3.74% | -5.57% |
Business Summary
Number of employees: 246
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 438 | 100.0 % | 582 | 100.0 % | +32.93% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 438 | 100.0 % | 582 | 100.0 % | +32.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 54 | 21-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
David Bradshaw
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Tricia Glover
CMP | Compliance Officer | - | - |
Luis Sanay
IRC | Investor Relations Contact | - | 22-02-28 |
Cate McCanless
PRN | Corporate Officer/Principal | - | - |
Audrey Murphy
HRO | Human Resources Officer | - | - |
Sharon Goldbach
PRN | Corporate Officer/Principal | - | - |
Ulrich Christian
LAW | General Counsel | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Jack Nielsen
BRD | Director/Board Member | 60 | 17-08-31 |
Gary Sender
BRD | Director/Board Member | 62 | 20-07-31 |
Antonio Gracias
BRD | Director/Board Member | 53 | 17-08-31 |
Peter Anastasiou
BRD | Director/Board Member | 53 | Nov. 04 |
Juan Sabater
BRD | Director/Board Member | 59 | 16-12-31 |
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Linda Szyper
BRD | Director/Board Member | 58 | 21-11-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,791,861 | 33,312,898 ( 58.66 %) | 0 | 58.66 % |
Company contact information
Harmony Biosciences Holdings, Inc.
630 West Germantown Pike Suite 215
19462, Plymouth Meeting
+
http://www.harmonybiosciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.57% | 1.73B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- HRMY Stock
- Company Harmony Biosciences Holdings, Inc.